Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × dostarlimab × 1 year × Clear all

Sponsor

Conditions

Neoplasms 13 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Pancreatic Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Stomach Neoplasms 2 Osteosarcoma 2 Locally Advanced Rectal Cancer (LARC) 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

pembrolizumab 23 Cisplatin 20 Carboplatin 13 Paclitaxel 10 Radiotherapy 8 Radiotherapy, Intensity-Modulated 7 Docetaxel 7 cemiplimab 6 Nivolumab 6 Fluorouracil 6 Radiation 5 durvalumab 4 Drug Therapy 4 Taxes 3 Surveys and Questionnaires 3 Cetuximab 3 Blood Specimen Collection 3 toripalimab 2 atezolizumab 2 alpha-2'-deoxythioguanosine 2 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Petrolatum 2 Pemetrexed 2 vistusertib 1 talazoparib 1 sitravatinib 1 regorafenib 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡